Woori Financial Group SEC Filings

WF NYSE

Welcome to our dedicated page for Woori Financial Group SEC filings (Ticker: WF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Parsing dividend policy shifts, FX exposure and non-performing loan ratios across Woori Financial Group’s nine subsidiaries can feel overwhelming. Credit-risk footnotes buried deep in a 300-page report often hide the metrics professionals need. If you have ever wondered how to locate Woori Financial Group insider trading Form 4 transactions before markets react, this page solves that problem.

Stock Titan delivers every disclosure the moment it posts to EDGAR, from a Woori Financial Group quarterly earnings report 10-Q filing to surprise 8-Ks. Our AI reads the fine print so you don’t have to. Within seconds you’ll receive plain-language highlights—Woori Financial Group SEC filings explained simply—covering capital adequacy, segment profits and risk factors. Need more depth? Launch an instant Woori Financial Group earnings report filing analysis that links cash-flow tables to management commentary. For governance focus, our tool spotlights Woori Financial Group proxy statement executive compensation alongside peer benchmarks.

Here’s what you can explore today:

10-K Insight: A Woori Financial Group annual report 10-K simplified with AI-generated summaries of credit quality and Basel ratios.
10-Q Trends: Compare NIM and loan growth by business line through interactive charts.
Form 4 Alerts: Track Woori Financial Group Form 4 insider transactions real-time and spot Woori Financial Group executive stock transactions Form 4 patterns.
8-K Briefings: Get Woori Financial Group 8-K material events explained in minutes—merger talks, regulatory notices, dividend changes.

Whether you’re understanding Woori Financial Group SEC documents with AI for the first time or refining a valuation model, our platform replaces hours of manual reading with clear, actionable insight.

07/01/2025 06:10 AM

Filing

[6-K] Woori Financial Group Inc. American Current Report (Foreign Issuer)

Rhea-AI Summary

Kura Oncology, Inc. (KURA) filed an 8-K to disclose that, on June 27, 2025, it executed a Co-Promotion and Medical Affairs Agreement with Kyowa Kirin, Inc. covering U.S. commercialization of its oral menin inhibitor ziftomenib for acute myeloid leukemia and other hematologic malignancies. The agreement operates under the previously announced November 20, 2024 Collaboration and License Agreement.

Main commercial terms

Co-promotion rights: Kyowa Kirin US will handle up to a specified share of sales details and must meet minimum detailing thresholds with qualified representatives.
Cost sharing: Both companies will split all U.S. co-promotion and medical affairs expenses 50/50.
Medical affairs leadership: Kura will lead U.S. medical affairs, with input from Kyowa Kirin; the parties will jointly craft a health economics and outcomes research strategy.
Term & termination: The pact lasts until the earlier of (i) mutual decision to cease commercialization or (ii) expiration of the U.S. collaboration term—defined as the latest of patent expiry, regulatory exclusivity expiry, or 10 years after first commercial sale. It terminates automatically if the broader Collaboration Agreement ends, and either side may end it for an uncured material breach.

The full agreement, with confidential portions redacted, will be filed as an exhibit to Kura’s Form 10-Q for the quarter ending June 30, 2025.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Woori Financial Group (WF)?

The current stock price of Woori Financial Group (WF) is $50.68 as of July 3, 2025.

What is the market cap of Woori Financial Group (WF)?

The market cap of Woori Financial Group (WF) is approximately 12.1B.

What is the core business of Woori Financial Group Inc.?

Woori Financial Group Inc. operates as a comprehensive financial services holding company that offers banking, credit card, investment banking, and asset management services to a diverse clientele.

Which business segments does Woori Financial Group focus on?

The company’s operations include distinct segments such as commercial banking, credit card operations, investment banking, capital markets, and asset management, each catering to specific financial needs.

How does the company generate revenue?

Revenue is generated through a combination of traditional banking services, innovative credit card products, and sophisticated investment banking and capital market activities, which together create a diversified income stream.

Who are the primary customers of Woori Financial Group Inc.?

Its services cater to individual consumers, corporate clients, and institutional investors, offering tailored financial solutions to meet a wide range of needs.

How does Woori Financial Group differentiate itself from competitors?

The company differentiates itself by offering an integrated suite of financial services that leverage deep industry expertise and a strong focus on risk management, ensuring a balanced approach to both consumer and corporate banking.

What industry-specific expertise does the company demonstrate?

Woori Financial Group employs advanced financial analytics and industry-specific knowledge in areas like risk-adjusted returns and liquidity management, showcasing its rigorous operational standards and expertise.

How does the company ensure operational excellence?

Through a robust regulatory framework, interlinked service segments, and adherence to high ethical and professional standards, Woori Financial Group maintains operational excellence and client trust.